170 related articles for article (PubMed ID: 32900629)
1. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.
Powell IJ; Chinni SR; Reddy SS; Zaslavsky A; Gavande N
Urol Oncol; 2021 Jan; 39(1):34-40. PubMed ID: 32900629
[TBL] [Abstract][Full Text] [Related]
2. Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.
Awasthi S; Berglund A; Abraham-Miranda J; Rounbehler RJ; Kensler K; Serna A; Vidal A; You S; Freeman MR; Davicioni E; Liu Y; Karnes RJ; Klein EA; Den RB; Trock BJ; Campbell JD; Einstein DJ; Gupta R; Balk S; Lal P; Park JY; Cleveland JL; Rebbeck TR; Freedland SJ; Yamoah K
Clin Cancer Res; 2021 Jan; 27(1):320-329. PubMed ID: 33037017
[TBL] [Abstract][Full Text] [Related]
3. Genes associated with prostate cancer are differentially expressed in African American and European American men.
Powell IJ; Dyson G; Land S; Ruterbusch J; Bock CH; Lenk S; Herawi M; Everson R; Giroux CN; Schwartz AG; Bollig-Fischer A
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):891-7. PubMed ID: 23515145
[TBL] [Abstract][Full Text] [Related]
4. Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk.
Creed JH; Berglund AE; Rounbehler RJ; Awasthi S; Cleveland JL; Park JY; Yamoah K; Gerke TA
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):246-253. PubMed ID: 31757784
[TBL] [Abstract][Full Text] [Related]
5. Identifying and treating ROBO1
Ferrari MG; Ganaie AA; Shabenah A; Mansini AP; Wang L; Murugan P; Davicioni E; Wang J; Deng Y; Hoeppner LH; Warlick CA; Konety BR; Saleem M
Prostate; 2020 Sep; 80(13):1045-1057. PubMed ID: 32687658
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.
Rayford W; Beksac AT; Alger J; Alshalalfa M; Ahmed M; Khan I; Falagario UG; Liu Y; Davicioni E; Spratt DE; Schaeffer EM; Feng FY; Mahal B; Nguyen PL; Den RB; Greenberger MD; Bradley R; Watson JM; Beamer M; Stamatakis L; Carmen DJ; Awasthi S; Hwang J; Weil R; Merisaari H; Mohamed N; Deane LA; Chakravarty D; Yadav KK; Yamoah K; Nair SS; Tewari AK
Commun Biol; 2021 Jun; 4(1):670. PubMed ID: 34083737
[TBL] [Abstract][Full Text] [Related]
7. Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men.
Gillard M; Javier R; Ji Y; Zheng SL; Xu J; Brendler CB; Crawford SE; Pierce BL; Griend DJV; Franco OE
Cancer Res; 2018 Nov; 78(21):6134-6145. PubMed ID: 30181178
[TBL] [Abstract][Full Text] [Related]
8. ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.
Parray A; Siddique HR; Kuriger JK; Mishra SK; Rhim JS; Nelson HH; Aburatani H; Konety BR; Koochekpour S; Saleem M
Int J Cancer; 2014 Dec; 135(11):2493-506. PubMed ID: 24752651
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.
Shiina M; Hashimoto Y; Kato T; Yamamura S; Tanaka Y; Majid S; Saini S; Varahram S; Kulkarni P; Dasgupta P; Mitsui Y; Sumida M; Tabatabai L; Deng G; Kumar D; Dahiya R
Oncotarget; 2017 Jan; 8(5):8356-8368. PubMed ID: 28039468
[TBL] [Abstract][Full Text] [Related]
10. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
11. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.
Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM
J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723
[TBL] [Abstract][Full Text] [Related]
12. Prostate tumors of native men from West Africa show biologically distinct pathways-A comparative genomic study.
Yamoah K; Asamoah FA; Abrahams AOD; Awasthi S; Mensah JE; Dhillon J; Mahal BA; Gueye SM; Jalloh M; Farahani SJ; Lal P; Rebbeck TR; Yarney J
Prostate; 2021 Dec; 81(16):1402-1410. PubMed ID: 34529278
[TBL] [Abstract][Full Text] [Related]
13. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
14. Cell line modeling to study biomarker panel in prostate cancer.
NickKholgh B; Fang X; Winters SM; Raina A; Pandya KS; Gyabaah K; Fino N; Balaji KC
Prostate; 2016 Feb; 76(3):245-58. PubMed ID: 26764245
[TBL] [Abstract][Full Text] [Related]
15. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.
Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA
Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899
[TBL] [Abstract][Full Text] [Related]
17. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract][Full Text] [Related]
18. Cytokine genetic polymorphisms and prostate cancer aggressiveness.
Zabaleta J; Su LJ; Lin HY; Sierra RA; Hall MC; Sartor AO; Clark PE; Hu JJ; Ochoa AC
Carcinogenesis; 2009 Aug; 30(8):1358-62. PubMed ID: 19474090
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.
Adekoya TO; Richardson RM
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585812
[TBL] [Abstract][Full Text] [Related]
20. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Ledet EM; Burgess EF; Sokolova AO; Jaeger EB; Hatton W; Moses M; Miller P; Cotogno P; Layton J; Barata P; Lewis BE; Nakazawa M; Zhu J; Dellinger B; Elrefai S; Nafissi NN; Egan JB; Shore N; McKay RR; Bryce AH; Cheng HH; Antonarakis ES; Sartor O
Prostate; 2021 May; 81(7):433-439. PubMed ID: 33792945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
